Nėra interneto ryšio – rodoma išsaugota puslapio versija.

Evotec SE

DEEUR
← Į akcijų filtrą

Evotec SE (XETRA:EVT) — Biotechnology: Pharmaceutical Preparations. Biržų, kuriose prekiaujama bendrovės akcijomis, skaičius: 3. Šiame puslapyje — kaina ir grafikas, dividendai, didžiausi akcininkai ir akcijų skaičiaus istorija.

Apie įmonę

Svetainė
evotec.com
Investuotojams
evotec.com/ir-news/investor-relations
Sektorius
Health Care · Biotechnology: Pharmaceutical Preparations
Būstinė
HAMBURG, Germany
Generalinis direktorius
Dr. Christian Wojczewski Ph.D.
Darbuotojai
4 461
Biržoje nuo
12.11.1999 (XETRA:EVT)
Apyvartoje esančios akcijos
177.69 mln.
Laisvai apyvartinės akcijos
135.49 mln.
Rinkos kapitalizacija
521.36 mln. EUR
Insaideriai
9.97%
Instituciniai investuotojai
60.05%
Šaka (SIC)
Pharmaceutical Preparations
Aprašymas

Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just – Evotec Biologics. The company is developing pharmaceutical products in various therapeutic areas, such as oncology, autoimmune, cancer, diabetes, heart failure, immunology, pain and inflammation, infectious, kidney, liver, respiratory, fibrotic and metabolic diseases, and rare diseases. It is also developingcentral nervous system (CNS) and cardiometabolic diseases; and animal and women health. The company has collaboration agreements with Mass General Brigham and Joslin Diabetes Center focusing on cardiometabolic diseases; BMS antiviral; Novo Nordisk cell therapy; University of Oxford; German Cancer Research Center; University Hospital in Hamburg; University of Toronto, Harvard, and Yale; Johns Hopkins University; Ospedale San Raffaele (OSR); and National University of Singapore. In addition, it has a partnership with LAB282, LAB150, beLAB2122, beLAB1407, LAB eN², Danube Labs, VC Amplitude Ventures, LaB eN2, and 65LAB. Further, the company serves pharma and biotechnology companies, academic institutions, patient advocacy groups, and venture capital. Evotec SE has strategic collaboration with Almirall, S.A. for the development of novel therapeutics for severe skin diseases, including a range of immune-mediated inflammatory conditions. The company collaborate with Odyssey Therapeutics, Inc. to designs and develops AI based discovery platform to discover new treatments in autoimmune and inflammatory diseases. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

Biržos ir tikeriai

BiržaTikerisValiutaKainaTipas
XETRA XetraEVT pagrindinisEUR3.028 -2.32%paprastosios akcijos
LSE London Stock Exchange0IRF IOBEUR25.98 +0.00%paprastosios akcijos
US USA StocksEVOTF OTCUSD3.325 -50.30%paprastosios akcijos

Kaina per 3 mėnesius

XETRA:EVT · EUR
kilimo diena kritimo diena dividendų ex data išmokėjimo dataUžveskite / palieskite dieną — atidarymo, uždarymo, aukščiausia ir žemiausia kainos

Dividendai

Dividendų išmokų nerasta (patikrinta 08.10.2026). Įmonė greičiausiai nemoka dividendų.

Šios savaitės naujienos

Per pastarąją savaitę jokių naujienų. Naujausios naujienos: 29.09.2026.

reklama

Didžiausi akcininkai

TurėtojasDalisAkcijosAtaskaitos data
First TRT Exch-Trd Fd.-F…1.46%2.6 mln.2026-06-30
VANGUARD STAR FUNDS-Vang…1.31%2.32 mln.2026-07-31
Brown Capital Mgmt Mutua…1.12%2 mln.2026-06-30
VANGUARD TAX-MANAGED FUN…0.87%1.55 mln.2026-06-30
iShares Trust-iShares Co…0.62%1.1 mln.2026-08-31
VANGUARD Intl Eqy. INDEX…0.37%660 9782026-07-31
DCF Advisers, LLC0.33%1.08 mln.2026-06-30
JNL Series Trust-JNL Mul…0.3%530 5352026-06-30
DFA INVESTMENT DIMENSION…0.27%477 8302026-07-31
iShares Trust-iShares MS…0.26%469 7002026-08-31
DFA INVESTMENT DIMENSION…0.23%414 2812026-07-31
WCM Investment Managemen…0.2%671 8842026-06-30
ABC Arbitrage SA0.11%371 9362026-06-30
Optiver Holding B.v.0.1%322 1532026-06-30
Morgan Stanley0.06%205 7632026-06-30
LPL Financial LLC0.05%166 0452026-06-30
Envestnet Asset Manageme…0.04%139 5962026-06-30
Old Mission Capital, LLC0.01%38 0322026-06-30
Pathstone Holdings, LLC0.01%35 7792026-06-30
Fore Capital, LLC0.01%31 3552026-06-30
Fidelity Concord Street…0%11 2722026-07-31